Carbamazepine and Fatal Eosinophilic Myocarditis

  • Salzman M
  • Valderrama E
  • Sood S
23Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

To the Editor: We describe a 13-year-old boy with attention deficit–hyperactivity disorder in whom fever, rash, conjunctivitis, hepatitis, myocarditis, and eosinophilia developed and who died about two months after the start of carbamazepine therapy. The cardiopulmonary resuscitation (CPR) of this patient was reported in an article on transvenous right ventricular pacing during CPR in children with acute cardiomyopathy.1 The child was an inpatient on a psychiatric unit. His carbamazepine treatment (100 mg twice a day) was initiated for aggressive and impulsive behavior after he did not respond to methylphenidate and clonidine. The carbamaz-epine dose was gradually increased to 800 mg . . .

Cite

CITATION STYLE

APA

Salzman, M. B., Valderrama, E., & Sood, S. K. (1997). Carbamazepine and Fatal Eosinophilic Myocarditis. New England Journal of Medicine, 336(12), 878–879. https://doi.org/10.1056/nejm199703203361216

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free